Virus safety considerations for recombinant factor VIII (rFVIII, Kogenate)
Haemophilia
.
1995 Apr:1 Suppl 2:22-3.
doi: 10.1111/j.1365-2516.1995.tb00118.x.
Author
D Arnold
1
Affiliation
1
Quality Assurance Division, Miles Inc., Berkeley, California, USA.
PMID:
27214844
DOI:
10.1111/j.1365-2516.1995.tb00118.x
No abstract available